VASAMED, Inc. VSMD

Company Overview

VASAMED, Inc. (traded publicly under the ticker VSMD in historical market references) was a U.S.-based medical technology company focused on non-invasive cardiovascular diagnostic and therapeutic systems. The company operated within the healthcare equipment and medical devices industry, with a primary emphasis on Enhanced External Counterpulsation (EECP) therapy systems and vascular diagnostic technologies used in cardiology and circulatory care. Public filings and historical investor disclosures indicate that its principal revenue drivers included sales, servicing, and licensing related to EECP equipment and associated healthcare technologies.

The company’s products were primarily targeted toward hospitals, cardiology practices, outpatient clinics, and healthcare providers treating patients with angina, coronary artery disease, and circulatory disorders. VASAMED’s strategic positioning centered on non-invasive treatment alternatives intended to improve blood flow and reduce symptoms in cardiovascular patients who were not ideal candidates for surgical intervention. The company evolved through a combination of internal product development and healthcare technology commercialization efforts, although public information regarding recent operating status and ongoing commercial activity is limited. Data inconclusive based on available public sources regarding current large-scale operational activity.